Marino, Stram & Associates LLC Palatin Technologies Inc Transaction History

Marino, Stram & Associates LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 19, 2019	SELL	$0.98 - $1.64 $64 - $108	-66 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$0.67 - $1.01 $44 - $66	66 New	66 $0
Q4 2018 Feb 14, 2019	SELL	$0.63 - $1.0 $41 - $66	-66 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$0.88 - $1.1 $58 - $72	66 New	66 $0

2.94K

Ticker PTN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,290,480
Market Cap $9.01M
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...

Get notified when there are updates to the investment portfolio of Marino, Stram & Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Marino, Stram & Associates LLC with notifications on news.